The intratumoural CD123+ cell number was the lowest in luminal/HER2− cancers; the difference was statistically significant in comparison to luminal/HER2+ (p < 0.006), HER2+ non-luminal (p < 0.001) and triple negative (p < 0.02) cancers. This evidence concerns the gene ERBB2 and cancer.